Finding, Treating, and Curing Rare Diseases
November 29 , 2021
Picture the following scenario: A patient presents with symptoms including numbness, tremors, and occasional weakness, among others. Genetic testing exists to check for rare cardiovascular diseases and defects, but it is expensive and not currently listed as part of the diagnosis protocol. Because of this, his doctors didn’t order the test. He suffered from these […]
Unblocking Part D, MarketView
October 19 , 2021
In specialty pharmacies, some medications may have partially blocked data. Manufacturers, payers, and specialty pharmacies can elect to block this data. When they do, it’s no longer visible to their allied and competitive healthcare stakeholders, like yourself. CareSet’s Part D Targeting product provides brand teams clarity using Medicare’s unblocked claims data. This allows us to […]
June 11 , 2021
CareSet is proud to announce that we are now the FIRST (that we know of) company with access to fee-for-service claims data (Part A, B & D), refreshed monthly, and with an industry best 2-week lag. CareSet is using this data to perform analysis of the ongoing COVID pandemic, and how it impacts Medicare patients […]
April 1 , 2020
The HOP Teaming Dataset from CareSet offers the most detailed and up-to-date picture of the patient-sharing relationships found between all U.S. Medicare providers HOUSTON (PRWEB) – Today CareSet released the updated HOP Teaming Dataset at Academy Health’s Datapalooza. The release is a game-changing dataset that offers the most detailed and up-to-date picture of patient-sharing relationships […]
October 19 , 2016
HOUSTON, TX (PRWEB) – CareSet Systems today introduced four new dynamic data science products to aid new drug launches. CareSet is the only company that offers 100% of Medicare A, B, and D claims data over six years to guide the introduction of new drugs and currently serves several big pharmaceutical companies with customized data […]